Boston's office vacancy rate hit 18.4 percent at the close of the second quarter of 2026 — the highest recorded figure since the aftermath of the dot-com collapse in 2002 — according to data tracked by commercial brokerage CBRE's Boston office. That single number has spooked some investors and heartened others, depending entirely on which neighborhood they hold paper in.
Fourth of July weekend tends to freeze dealmaking. But this year, the holiday pause arrives at a moment when capital allocators are genuinely uncertain how to read the city's commercial property signals, and the consequences of misreading them are substantial. Interest rates have eased modestly since the Federal Reserve's March 2026 pause, making debt cheaper than it was eighteen months ago, but not cheap enough to paper over fundamentally weak demand in older, less amenity-rich stock.
Two Markets Inside One City
Walk from Post Office Square in the Financial District to the corner of Seaport Boulevard and Congress Street and you're covering less than a mile — but you're crossing what analysts now openly describe as two separate office markets. In the Financial District, several Class B towers along Franklin Street and Federal Street are carrying asking rents between $42 and $48 per square foot annually, down roughly 12 percent from their 2022 peaks, with landlords offering rent abatements of up to nine months to attract tenants. Buildings constructed before 1990 are struggling hardest. BXP, the Boston-headquartered real estate investment trust formerly known as Boston Properties, has been selectively offloading older assets and reinvesting in life-science-adjacent developments closer to Kendall Square in Cambridge.
The Seaport District tells a different story. Amazon's lease at 111 Harbor Way remains the anchor that other landlords point to when making their pitch to prospective tenants, and new asking rents in the neighborhood's premium towers are holding at $72 to $80 per square foot. Breakthrough Properties, which focuses on life sciences and tech-forward office product, signed a development agreement in early 2026 for a parcel near the Raymond L. Flynn Marine Park. Institutional investors from New York and Toronto have been active buyers of Seaport assets, drawn by the concentration of biotech and fintech firms that have taken root there since 2020.
What the Investment Flows Are Signaling
Follow the money and the message is nuanced. Total commercial real estate investment volume in Greater Boston reached approximately $3.1 billion in the first half of 2026, according to industry figures compiled by JLL's Boston team. That's down from $4.7 billion in the same period of 2024, but the composition has shifted as meaningfully as the total. Life science conversions and mixed-use projects with residential components are absorbing a disproportionate share of incoming capital, while pure-play suburban office parks — particularly those in the Route 128 corridor towns like Waltham and Burlington — are attracting almost none.
The green building premium is also becoming measurable rather than theoretical. Properties in Boston with LEED Platinum certification or better are commanding rents approximately 8 percent above equivalent non-certified space in the same submarket, a gap that has widened since the city tightened its Building Emissions Reduction and Disclosure Ordinance compliance deadlines in January 2026. Owners of older stock face a hard calculation: retrofit costs averaging $15 to $25 million for a mid-size tower, or accept accelerating vacancy and declining valuations.
For investors and tenants trying to position themselves over the next 18 months, the practical read is this: assets within walking distance of the MBTA's Silver Line and Red Line stations, with modern HVAC, genuine outdoor amenity space, and sub-20,000 square foot floor plates favored by growing tech firms, will continue to attract competitive bidding. Everything else requires either a conviction thesis on conversion potential or a willingness to hold through a longer recovery cycle. The city's life sciences pipeline — anchored by the Longwood Medical Area and the ongoing build-out around Kendall Square — remains the single strongest argument that Boston's commercial market has a floor other gateway cities cannot claim with equal confidence.